NCT07013851
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07013851
Title Clinical Trial to Assess the Efficacy of Dostarlimab as Neoadjuvant Therapy in Patients With MMRd/MSI-H Stage II-III Endometrial Cancer (NADIA)
Acronym NADIA
Recruitment Not yet recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors Grupo Español de Investigación en Cáncer de Ovario
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP